Response to letter to the editor: the clinical utility of diagnostic T cell assays for COVID-19

Expert Rev Clin Immunol. 2021 Nov;17(11):1159-1161. doi: 10.1080/1744666X.2021.1982386. Epub 2021 Oct 20.

Rohan Ameratunga^{1

2

3}, See-Tarn Woon², Anthony Jordan¹, Hilary Longhurst^{1

4}, Euphemia Leung^{5

6}, Richard Steele^{2

7}, Klaus Lehnert^{8

6}, Russell Snell⁸, Anna E S Brooks^{8

6}

¹ Department of Clinical Immunology, Auckland Hospital, Auckland, New Zealand.
² Department of Virology and Immunology, Auckland Hospital, Auckland, New Zealand.
³ Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁴ Department of Medicine, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁵ Auckland Cancer Society Research Centre, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
⁶ Maurice Wilkins Centre, University of Auckland, Auckland, New Zealand.
⁷ Department of Respiratory Medicine, Wellington Hospital, Wellington, New Zealand.
⁸ School of Biological Sciences, University of Auckland, Auckland, New Zealand.

No abstract available

Keywords: COVID-19; SARS-CoV-2; Tcell assay; cellular response; thymidine uptake.

Publication types

This paper is not funded.